These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 12452515)

  • 21. [Botulinum toxin for palatal myoclonus and spastic dysphonia].
    Greenberg E; Giladi N; Meer J; Uri N; Honigman S
    Harefuah; 1993 Dec; 125(11):402-4, 448. PubMed ID: 8112664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of hemifacial spasm with botulinum toxin].
    Tanaka M; Hakuto T; Akatsuka M; Morimoto E; Hama T; Morimoto M; Hiraga Y; Hyodo M
    Masui; 1993 Jun; 42(6):883-7. PubMed ID: 8320807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin.
    Consens Statement; 1990 Nov 12-14; 8(8):1-20. PubMed ID: 2098181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin treatment of occupational and focal hand dystonia.
    Karp BI
    Mov Disord; 2004 Mar; 19 Suppl 8():S116-9. PubMed ID: 15027063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin-A for the treatment of hemifacial spasm.
    Cuevas C; Madrazo I; Magallón E; Zamorano C; Neri G; Reyes E
    Arch Med Res; 1995; 26(4):405-8. PubMed ID: 8555735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of simultaneous bilateral botulinum toxin injections for abductor spasmodic dysphonia.
    Stong BC; DelGaudio JM; Hapner ER; Johns MM
    Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):793-5. PubMed ID: 16172357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Frequency of side effects after botulinum toxin A injections in neurology, rehabilitation and gastroenterology].
    Sławek J; Madaliński MH; Maciag-Tymecka I; Duzyński W
    Pol Merkur Lekarski; 2005 Mar; 18(105):298-302. PubMed ID: 15997637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment with botulinum neurotoxin of gastrointestinal smooth muscles and sphincters spasms.
    Brisinda G; Bentivoglio AR; Maria G; Albanese A
    Mov Disord; 2004 Mar; 19 Suppl 8():S146-56. PubMed ID: 15027068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxins: pharmacology and its current therapeutic evidence for use.
    Panicker JN; Muthane UB
    Neurol India; 2003 Dec; 51(4):455-60. PubMed ID: 14742921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin in otolaryngology: a review of its actions and opportunities for use.
    Neuenschwander MC; Pribitkin EA; Sataloff RT
    Ear Nose Throat J; 2000 Oct; 79(10):788-9, 792, 794 passim. PubMed ID: 11055100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of various movement disorders with botulinum A toxin injection: an experience of 900 patients.
    Poungvarin N; Devahastin V; Viriyavejakul A
    J Med Assoc Thai; 1995 Jun; 78(6):281-8. PubMed ID: 7561552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of focal dystonia with botulinic toxin].
    Gracia F; Castillo LC
    Rev Med Panama; 1996 Sep; 21(3):121-31. PubMed ID: 9280925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum toxin therapy of eye muscle disorders. Safety and effectiveness. American Academy of Ophthalmology.
    Ophthalmology; 1989 Sep; Suppl():37-41. PubMed ID: 2779991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin therapy.
    Savino PJ; Maus M
    Neurol Clin; 1991 Feb; 9(1):205-24. PubMed ID: 2011110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum neurotoxin: the ugly duckling.
    Koussoulakos S
    Eur Neurol; 2009; 61(6):331-42. PubMed ID: 19365125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Botulinum toxin in the treatment of frontoglabellar and periorbital wrinkles. An initial study].
    Ascher B; Klap P; Marion MH; Chanteloub F
    Ann Chir Plast Esthet; 1995 Feb; 40(1):67-76. PubMed ID: 7668808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mechanism of action, clinical indication and results of treatment of botulinum toxin].
    Lagueny A; Burbaud P
    Neurophysiol Clin; 1996; 26(4):216-26. PubMed ID: 8975111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Botulinum toxin. Development for therapeutic purposes].
    Ceballos-Baumann A
    Nervenarzt; 2008 Jun; 79 Suppl 1():3-8. PubMed ID: 18927957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of botulinum A toxin injection in the management of hemifacial spasm].
    Hakuto T; Kurioka M; Hiraga Y; Ko K; Tanaka H; Morimoto E; Morimoto M; Hyodo M
    Masui; 1992 May; 41(5):811-6. PubMed ID: 1608159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.